Logo novo nordisk

novo nordisk

Registrada

Mista · Brasil

Outros setoresTecnologiaEducaçãoSoftware e TISaúde e beleza

Marca registrada: vale avaliar o risco de conflito

A marca "novo nordisk" está registrada no Brasil. Se você usa ou pretende usar um nome similar, pode haver risco de conflito. Vale olhar classes, histórico e despachos antes de decidir o próximo passo.

Panorama da marca

Situação INPI
Deferimento da petição
Tramitação até registro
1 ano e 3 meses
Eventos no processo
4
Última atualização
14 de junho de 2022

Dados do processo

Titular
Novo Nordisk A/S
Número do processo
501542011
Número de registro
501542011
Natureza
Madri Produto/Serviço
Data do depósito
03 de abril de 2020
Data do registro
27 de julho de 2021
Válido até
03 de abril de 2030

Produtos e serviços cobertos

Classe 1Outros setores

Chemical preparations for use in industry; chemical additives; chemical additives for use in the manufacture of pharmaceuticals, cosmetics, hair lotions, disinfectants; chemical diagnostic reagents for industrial use; chemical preparations for use in the oil industry.;

Classe 5Outros setores

Pharmaceutical preparations for the treatment of diabetes and obesity; pharmaceutical preparations for haemostasis management and for the treatment of sickle cell disease; pharmaceutical preparations for the treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease; pharmaceutical preparations for hormone therapy and stem cells for medical purposes; drug delivery devices containing the abovementioned products; chemical preparations for use in medical devices.;

Classe 9Tecnologia

Electronic publications, namely, leaflets, books, booklets, handouts, magazines as well as medical, instructional and teaching material in the field of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; downloadbale electronic publications featuring electronic reports containing results from clinical trials and studies in the field of prevention and treatment of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; software applications for use with mobile devices for monitoring and the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; computer hardware and software, for use with medical injection devices for collecting, transmitting, and displaying medical data; medical software for the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; software as a medical device.;

Classe 10Outros setores

Medical and surgical apparatus and instruments, namely, hypodermic syringes and pens; medical apparatus and instruments for reconstitution and injection of pharmaceutical preparations; medical apparatus and instruments, namely, injection devices for administration of pharmaceutical preparations, medical infusion pumps, infusion pump controllers, adhesive infusion devices; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; medical and surgical apparatus and instruments, namely, injection devices for the administration of pharmaceutical preparations and the wireless transmission of medical data in connection with the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; medical devices, namely, automatic needle insertion devices, protection caps for hypodermic syringes and medical pens; needles for injections; cartridges and carpules for administration pharmaceutical preparations.;

Classe 41Educação

Educational services, namely, organizing and conducting educational programmes, coaching and training services for patients and healthcare professionals related to management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; arranging and conducting of conferences, congresses, seminars, symposiums and workshops related to the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment.;

Classe 42Software e TI

Providing scientific information on diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; providing websites and mobile apps featuring technology that enables users to record, track, and generate reports regarding the condition, treatment and the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; computer services, namely providing access to data concerning medical analysis and management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment.;

Classe 44Saúde e beleza

Providing medical services via websites and mobile apps for the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; providing medical information and medical counselling the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment.;

Classificação de Viena

Elementos figurativos identificados na marca, segundo a classificação internacional de Viena (OMPI).

26.1.1Figuras e sólidos geométricos
26.1.4Figuras e sólidos geométricos
27.5.1Formas de escrita, numerais
29.1.4Cores
3.4.1Animais

Linha do tempo do processo

4 eventos

Movimentações mais recentes da marca “novo nordisk” publicadas na Revista da Propriedade Industrial (RPI). O detalhe de cada despacho fica na consulta completa.

  1. Andamento14 de jun. de 2022RPI 2684

    Deferimento da petição

    Detalhes na consulta completa
  2. Concessão / deferimento27 de jul. de 2021RPI 2638

    Concessão de registro em designação

    Detalhes na consulta completa
  3. Andamento13 de abr. de 2021RPI 2623

    Deferimento de designação

    Detalhes na consulta completa

Saiba mais (+1 movimentação)

Veja o histórico completo de despachos desta marca e receba alertas de novas movimentações.

Ver histórico completo

Presença publicitária

Um anunciante usa este nome, mas não é o titular desta marca

  • NOVO NORDISK FARMACEUTICA DO BRASIL LTDA

    CNPJ 82.277.955/0002-36 · SÃO PAULO/SP

    12 filmes publicitários · 2020–2024

O uso do nome em publicidade pode indicar mercado ativo, mas não prova titularidade da marca. Pode haver uso por terceiro, coincidência comercial ou conflito de marca.

Presença publicitária TrademarkIQ. Sinal informativo para pesquisa e SEO, não substitui verificação jurídica.

O que fazer se a sua marca se aproxima de "novo nordisk"?

Conflitos de marcas no Brasil são resolvidos com base na anterioridade do depósito, nas classes de Nice e no segmento de atuação. O processo tem várias fases e pode ficar complexo quando o nome é parecido ou o mercado se cruza. Uma leitura cuidadosa ajuda a decidir se vale seguir, ajustar ou recuar.

A TrademarkIQ cruza histórico, decisões e padrões de aprovação por classe e setor em uma base com +6 milhões de processos brasileiros. Isso ajuda a enxergar o risco com mais contexto e a encontrar o melhor caminho comercial e jurídico para a sua marca.

Vigilância de marca

Seja avisado antes que vire problema

Monitoramento contínuo: receba um alerta a cada novo depósito que possa colidir com novo nordisk ou com a sua marca — a tempo de se opor dentro do prazo.

Monitorar marca

Dados actualizados a partir de uma base com +6 milhões de marcas brasileiras analisadas. Esta página é informativa e não substitui parecer jurídico, mas ajuda a orientar a decisão com mais contexto comercial e técnico.